Logo image
Back
Opioid Use in Pelvic Fractures: The Impact of Opioid Prescribing Laws in Pennsylvania
Journal article   Peer reviewed

Opioid Use in Pelvic Fractures: The Impact of Opioid Prescribing Laws in Pennsylvania

Nicole Ann E. Villa, Kristina Shum, Allison Atkinson, Adrian Ong, Alison Muller and Eduardo Espiridion
The American surgeon, v 90(7), pp 1937-1939
Jul 2024
DOI: https://doi.org/10.1177/00031348241241644
PMID: 38516756
Featured in Collection :   UN Sustainable Development Goals @ Drexel

Abstract

Life Sciences & Biomedicine Science & Technology Surgery
Pennsylvania's Prescription Drug Monitoring Program (PDMP) was established in 2016, but its impact on opioid use for pelvic fractures is understudied. We compared opioid use in 277 pelvic fracture cases between two periods: 2015-2017 (T1) and 2018-2020 (T2). Outcomes included daily inpatient morphine milligram equivalents (MME), long-term opioid use (LOU) 60-90 days post-discharge, and intermediate-term opioid use (IOU) 30-60 days post-discharge. T1 and T2 had comparable baseline characteristics. T2 was associated with a decrease in average daily inpatient MME (58.6 vs 78.5, P = .02), particularly in younger patients. Regression analyses showed age and Injury Severity Score (ISS) were significant predictors for daily inpatient MME, while time period was not. Geriatric patients in T2 had significantly decreased IOU (30% vs 9%, P = .05). Pelvic fracture type and daily MME predicted IOU, while pelvic fracture type predicted LOU. This study suggests a modest impact of these laws, but further study is needed.

Metrics

12 Record Views
2 citations in Web of Science
1 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: SDGs in the Output

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Web of Science research areas
Surgery
Logo image